Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublications en collaboration avec des chercheurs de University of Michigan–Ann Arbor (26)
2024
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
Cancer Research Communications, Vol. 4, Núm. 7, pp. 1677-1689
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116
-
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncology, Vol. 8, Núm. 3
-
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
BLOOD CANCER DISCOVERY, Vol. 3, Núm. 6
2021
-
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547
-
Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features
JAMA Network Open, Vol. 4, Núm. 7
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550
2020
-
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Leukemia, Vol. 34, Núm. 12, pp. 3298-3309
2019
-
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
Nature Protocols, Vol. 14, Núm. 3, pp. 639-702
2017
-
BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells
Cancer Discovery, Vol. 7, Núm. 5, pp. 506-521
2016
-
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Cell, Vol. 166, Núm. 4, pp. 963-976
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
-
The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling
Journal of Biological Chemistry, Vol. 289, Núm. 40, pp. 27727-27743
2013
-
A novel fatty acid lipophilic index and risk of CHD in US men: The Health Professionals Follow-Up Study
British Journal of Nutrition, Vol. 110, Núm. 3, pp. 466-474
-
A novel fatty acid profile index-the lipophilic index-and risk of myocardial infarction
American Journal of Epidemiology, Vol. 178, Núm. 3, pp. 392-400